Institute of Applied Brain Sciences, Waseda University, Tokorozawa, Japan; Shokei Gakuin University, Natori, Japan; Graduate School of Dentistry, Tohoku University, Sendai, Japan.
Institute of Applied Brain Sciences, Waseda University, Tokorozawa, Japan; Department of Environmental Medicine and Behavioral Science, Kindai University Faculty of Medicine, Osakasayama, Japan.
Int J Hyg Environ Health. 2018 Sep;221(8):1085-1096. doi: 10.1016/j.ijheh.2018.08.001. Epub 2018 Aug 14.
Recently, with rapid changes in the Japanese lifestyle, the clinical condition of patients with multiple chemical sensitivity (MCS) may also have undergone change. Thus, we conducted a new survey for subjective symptoms, ongoing chemical exposures, the prevalence of allergic diseases, and presumed onset/trigger factors in patients with MCS and compared results with those of an old survey from ten years ago.
The new survey was conducted from 2012 to 2015 and the old survey was independently conducted from 1999 to 2003, meaning it was not a follow-up study. Patients were initially diagnosed by physicians at five medical institutions with MCS specialty outpatient services, with 111 and 103 patients participating in the new and old surveys, respectively. The controls were a general population living in Japan, with 1313 and 2382 participants in the new and old surveys, respectively. Subjective symptoms and ongoing chemical exposure were evaluated using a quick environmental exposure sensitivity inventory. Additionally, from clinical findings recorded by an attending physician, the prevalence of allergic diseases and presumed onset/trigger factors were evaluated. Differences between new and old surveys were analyzed using logistic regression analyses and significance tests.
Compared with ten years ago: (1) Regarding factors affecting patients with ongoing chemical exposures, the proportion of patients affected decreased significantly for two items only (insecticides and second-hand smoke). The proportion of controls showing ongoing exposure to 8 out of 10 items changed significantly. (2) In patients, scores for chemical intolerances, other intolerances, and life impacts increased significantly. (3) In terms of the prevalence of allergic diseases among patients with MCS, bronchial asthma (adjusted odds ratio [AOR]: 5.19), atopic dermatitis (AOR: 3.77), allergic rhinitis (AOR: 5.34), and food allergies (AOR: 2.63) increased significantly, while hay fever (AOR: 0.38) and drug allergies (AOR: 0.40) decreased significantly. (4) With regard to construction and renovation, which was the presumed predominant onset/trigger factor for MCS 10 years ago, this decreased from 68.9% to 35.1%; in contrast, electromagnetic fields (0.0%-26.1%), perfume (0.0%-20.7%), and medical treatment (1.9%-7.2%) increased significantly, confirming the diversification of onset/trigger factors.
Compared to ten years ago, for patients with MCS, an increase in avoidance behavior toward chemical substance exposures, which were presumed to be aggravating factors for symptoms, was confirmed. It has been suggested that the ongoing chemical exposure of the general population in Japan has largely changed. In addition, for patients with MCS, chemical intolerances and life impacts have become severe, the prevalence of the main allergic diseases has increased, and onset/trigger factors have become diversified.
近年来,随着日本生活方式的快速变化,多发性化学敏感性(MCS)患者的临床状况也可能发生变化。因此,我们对 MCS 患者的主观症状、持续的化学暴露、过敏性疾病的流行情况和假定的发病/触发因素进行了新的调查,并将结果与十年前的旧调查进行了比较。
新调查于 2012 年至 2015 年进行,旧调查于 1999 年至 2003 年独立进行,并非随访研究。患者最初由五家具有 MCS 专科门诊服务的医疗机构的医生诊断,新调查和旧调查分别有 111 名和 103 名患者参加。对照组是居住在日本的普通人群,新调查和旧调查分别有 1313 名和 2382 名参与者。使用快速环境暴露敏感性清单评估主观症状和持续的化学暴露。此外,根据主治医生记录的临床发现,评估了过敏性疾病和假定的发病/触发因素的流行情况。使用逻辑回归分析和显著性检验分析新调查和旧调查之间的差异。
与十年前相比:(1)对于影响持续化学暴露的患者的因素,仅两种(杀虫剂和二手烟)的受影响患者比例显著下降。八种物品中有八种持续暴露的对照组的比例发生了显著变化。(2)在患者中,对化学物质不耐受、其他不耐受和生活影响的评分显著增加。(3)就 MCS 患者过敏性疾病的流行情况而言,支气管哮喘(调整后的优势比 [AOR]:5.19)、特应性皮炎(AOR:3.77)、过敏性鼻炎(AOR:5.34)和食物过敏(AOR:2.63)显著增加,而花粉热(AOR:0.38)和药物过敏(AOR:0.40)显著减少。(4)至于建筑和装修,这是十年前 MCS 的主要发病/触发因素,从 68.9%下降到 35.1%;相比之下,电磁场(0.0%-26.1%)、香水(0.0%-20.7%)和医疗(1.9%-7.2%)显著增加,证实了发病/触发因素的多样化。
与十年前相比,MCS 患者对被认为是症状加重因素的化学物质暴露的回避行为有所增加,这一点得到了证实。日本普通人群持续的化学暴露情况发生了很大变化。此外,对于 MCS 患者,化学不耐受和生活影响变得更加严重,主要过敏性疾病的流行情况有所增加,发病/触发因素也变得多样化。